ABIOMED INC (ABMD) Stock Analyst Earnings Estimates
NASDAQ:ABMD - Nasdaq - US0036541003 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 840.9M 9.29% | 847.5M 0.78% | 1.032B 21.74% | 1.158B 12.24% | 1.34B 15.72% | 1.54B 14.93% | 1.684B 9.35% | 1.78B 5.70% | |
| EBITDA YoY % growth | 269.6M 12.85% | 253.7M -5.90% | 284.795M 12.26% | 296.99M 4.28% | 374.32M 26.04% | 454.29M 21.36% | 524.55M 15.47% | 571.17M 8.89% | |
| EBIT YoY % growth | 249.2M 10.85% | 229.6M -7.87% | 256.706M 11.81% | 271.28M 5.68% | 333.59M 22.97% | 408.5M 22.46% | 468.71M 14.74% | 508.63M 8.52% | |
| Operating Margin | 29.63% | 27.09% | 24.88% | 23.43% | 24.89% | 26.53% | 27.83% | 28.57% | |
| EPS YoY % growth | 4.52 -11.37% | 4.93 9.07% | 4.73 -4.06% | 4.91 3.83% | 5.69 15.86% | 7.01 23.15% | 8.21 17.16% | 9.81 19.50% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | 1.37 21.41% | 1.46 26.18% | 1.51 21.18% |
| Revenue Q2Q % growth | 306.95M 17.53% | 341.19M 26.44% | 356.08M 28.48% |
| EBITDA Q2Q % growth | 84.32M -1.79% | 93.364M 0.29% | 99.722M 37.23% |
| EBIT Q2Q % growth | 69.063M 6.15% | 76.76M 18.09% | 80.118M 21.30% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 1.30 26.21% | 1.37 | -0.07 | -5.24% |
| Q1 2023 Q2Q % growth | 1.25 -11.35% | 1.08 | 0.17 | 15.98% |
| Q4 2022 Q2Q % growth | 1.16 -6.45% | 1.00 | 0.16 | 15.65% |
| Q3 2022 Q2Q % growth | 1.13 -16.30% | 1.06 | 0.07 | 6.67% |
| Q2 2022 Q2Q % growth | 1.03 -24.26% | 1.08 | -0.05 | -4.35% |
| Q1 2022 Q2Q % growth | 1.41 43.88% | 1.11 | 0.30 | 27.23% |
| Q4 2021 Q2Q % growth | 1.24 77.14% | 0.97 | 0.27 | 27.97% |
| Q3 2021 Q2Q % growth | 1.35 -10.60% | 0.99 | 0.36 | 36.06% |
| Q2 2021 Q2Q % growth | 1.36 32.04% | 1.08 | 0.28 | 26.47% |
| Q1 2021 Q2Q % growth | 0.98 -23.44% | 1.12 | -0.14 | -12.35% |
| Q4 2020 Q2Q % growth | 0.70 -35.78% | 1.15 | -0.45 | -39.19% |
| Q3 2020 Q2Q % growth | 1.51 55.67% | 0.94 | 0.57 | 60.70% |
| Q2 2020 Q2Q % growth | 1.03 -5.50% | 0.30 | 0.73 | 243.60% |
| Q1 2020 Q2Q % growth | 1.28 -34.36% | 0.95 | 0.33 | 34.09% |
| Q4 2019 Q2Q % growth | 1.09 | 1.11 | -0.02 | -1.72% |
| Q3 2019 Q2Q % growth | 0.97 | 0.95 | 0.02 | 2.39% |
| Q2 2019 Q2Q % growth | 1.09 | 0.99 | 0.10 | 10.27% |
| Q1 2019 Q2Q % growth | 1.95 | 1.10 | 0.85 | 77.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 265.921M 7.16% | 319.97M | -54.049M | -16.89% |
| Q1 2023 Q2Q % growth | 277.149M 9.73% | 314.41M | -37.261M | -11.85% |
| Q4 2022 Q2Q % growth | 269.85M 11.88% | 301.28M | -31.43M | -10.43% |
| Q3 2022 Q2Q % growth | 261.176M 12.72% | 279.01M | -17.834M | -6.39% |
| Q2 2022 Q2Q % growth | 248.142M 18.28% | 282.77M | -34.628M | -12.25% |
| Q1 2022 Q2Q % growth | 252.585M 53.17% | 273.02M | -20.435M | -7.48% |
| Q4 2021 Q2Q % growth | 241.2M 16.69% | 257.9M | -16.7M | -6.48% |
| Q3 2021 Q2Q % growth | 231.7M 4.56% | 252.61M | -20.91M | -8.28% |
| Q2 2021 Q2Q % growth | 209.8M 2.34% | 247.4M | -37.6M | -15.20% |
| Q1 2021 Q2Q % growth | 164.9M -20.61% | 234.99M | -70.09M | -29.83% |
| Q4 2020 Q2Q % growth | 206.7M -0.19% | 230.11M | -23.41M | -10.17% |
| Q3 2020 Q2Q % growth | 221.6M 10.47% | 202.91M | 18.69M | 9.21% |
| Q2 2020 Q2Q % growth | 205M 12.76% | 154.13M | 50.87M | 33.00% |
| Q1 2020 Q2Q % growth | 207.7M 15.39% | 211.31M | -3.61M | -1.71% |
| Q4 2019 Q2Q % growth | 207.1M | 231.53M | -24.43M | -10.55% |
| Q3 2019 Q2Q % growth | 200.6M | 210.58M | -9.98M | -4.74% |
| Q2 2019 Q2Q % growth | 181.8M | 214.9M | -33.1M | -15.40% |
| Q1 2019 Q2Q % growth | 180M | 223.29M | -43.29M | -19.39% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.13% | N/A | 1.46% | N/A |
| Revenue | -3.26% | N/A | -1.36% | N/A |